Religion and support for genomic healthcare: An exploratory study of the US public and faith leaders.

宗教和对基因组医疗保健的支持:对美国公众和信仰领袖的探索性研究。

基本信息

  • 批准号:
    10708964
  • 负责人:
  • 金额:
    $ 47.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary Religion is a primary driver of concerns with genomics and genomic healthcare (GGH). It is vital for research on the ethical, legal, and social implications (ELSI) of genomics to understand the role of religion in shaping public attitudes toward GGH. Ninety percent of the US public believes in some kind of higher power and 55% pray daily. The US public attends religious services at a rate 3 times higher than scientists in the US, who are at risk of misunderstanding the role religion plays in attitudes toward GGH. Further, Black, Hispanic, and rural populations attend religious services more frequently than the general US public. Concerns with GGH activities may lead to lower levels of engagement of GGH, which may in turn contribute to health disparities. This project aims to understand why higher levels of religious practice are associated with greater concerns with GGH activities. Additionally, this project will interview faith leaders to identify how public health genomics might engage faith communities in ways that are respectful and constructive. While some concerns with healthcare technologies may disappear with new information, others stem from worldviews, deep moral commitments, or mistrust of the healthcare system. Engaging religious communities is essential to identify which concerns can be addressed with information, which call for alternative responses, and what alternative responses might look like. Very few models exist for genomic public health engagement with religion, particularly models that directly address value-laden concerns.13,14 This project will achieve two specific aims: 1. Quantitatively examine which aspects of religion explain its influence on support for GGH activities. We will survey 4800 adults in the US to examine the association of religious variables with support for GGH activities such as prenatal genetic testing, gene editing, and mRNA vaccines. We will generate rich descriptive data and explore how and when diverse religious variables predict support for, or opposition to, GGH activities. 2. Explore how genomic public health can engage with religious communities in a way that is respectful and constructive. We will conduct in-depth interviews via Zoom with 180 faith leaders—30 from each of six groups: Evangelical, Mainline Protestant, Historically Black, and Catholic Christianity, Judaism, and Islam. These groups represent the largest religious groups in the US, comprising 90% of those with a religious affiliation. Interviews will explore several different issues: What are their views on GGH activities? Is diversity of opinion on these matters tolerated within their community? To what extent are concerns with GGH activities principled and to what extent might further information be helpful? How might genomic public health engage religious communities in a way that is both respectful and constructive?
项目摘要 宗教是关注基因组学和基因组医疗保健(GGH)的主要驱动力。这对研究至关重要 关于基因组学的伦理、法律的和社会影响(ELSI),以了解宗教在塑造 公众对GGH的态度。90%的美国公众相信某种更高的权力, 每天祈祷。美国公众参加宗教服务的比率是美国科学家的3倍, 有可能误解宗教在对GGH的态度中所起的作用。此外,黑人,西班牙裔和农村 美国民众参加宗教仪式的频率高于一般美国民众。关注GGH 活动可能导致GGH的参与程度较低,这反过来又可能导致健康差距。 这个项目旨在了解为什么更高层次的宗教实践与更大的关注有关 GGH的活动。 此外,该项目将采访宗教领袖,以确定公共卫生基因组学如何参与 以尊重和建设性的方式建立信仰社区。虽然一些关于医疗保健的担忧 技术可能会随着新的信息而消失,其他的则源于世界观,深刻的道德承诺, 或者对医疗系统的不信任让宗教团体参与进来对于确定哪些关切至关重要 可以通过信息来解决,这些信息需要替代反应,以及哪些替代反应可能 看起来像。很少有基因组公共卫生与宗教接触的模式,特别是 13,14该项目将实现两个具体目标: 1.定量研究宗教的哪些方面解释了它对GGH活动支持的影响。 我们将在美国调查4800名成年人,以研究宗教变量与GGH支持的关联 产前基因检测、基因编辑和mRNA疫苗等活动。我们将生成丰富的描述性 数据和探索如何以及何时不同的宗教变量预测支持,或反对,GGH活动。 2.探索基因组公共卫生如何以一种 尊重和建设性。我们将通过Zoom对180位信仰领袖进行深入采访,其中30位来自 六个团体:福音派、主流新教、历史黑人、天主教、犹太教, 和伊斯兰教。这些团体代表了美国最大的宗教团体,占美国90%的宗教团体。 宗教信仰访谈将探讨几个不同的问题:他们对GGH活动的看法是什么?是 在他们的社区内容忍这些问题上的不同意见?对GGH的关注程度 原则性活动,进一步的信息在多大程度上可能有所帮助?基因组公共卫生 以尊重和建设性的方式与宗教团体接触?

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James M Dubois其他文献

James M Dubois的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James M Dubois', 18)}}的其他基金

SHARING QUALITATIVE RESEARCH DATA: IDENTIFYING AND ADDRESSING ETHICAL AND PRACTICAL BARRIERS
共享定性研究数据:识别和解决道德和实践障碍
  • 批准号:
    10614306
  • 财政年份:
    2022
  • 资助金额:
    $ 47.39万
  • 项目类别:
Religion and support for genomic healthcare: An exploratory study of the US public and faith leaders.
宗教和对基因组医疗保健的支持:对美国公众和信仰领袖的探索性研究。
  • 批准号:
    10576741
  • 财政年份:
    2022
  • 资助金额:
    $ 47.39万
  • 项目类别:
Identifying and exploring solutions to the ethical challenges of ApoL1 testing of donors with recent African ancestry through mixed methods research with stakeholders
通过与利益相关者的混合方法研究,确定并探索针对具有非洲血统的捐赠者的 ApoL1 测试的伦理挑战的解决方案
  • 批准号:
    10112755
  • 财政年份:
    2019
  • 资助金额:
    $ 47.39万
  • 项目类别:
Understanding and addressing challenges to informed consent and research compliance during Covid-19 research
了解并应对 Covid-19 研究期间知情同意和研究合规性的挑战
  • 批准号:
    10164294
  • 财政年份:
    2018
  • 资助金额:
    $ 47.39万
  • 项目类别:
Implementing Evidence-based Informed Consent Practices to Address the Risk of Alzheimer's Dementia and Cognitive Impairment in Clinical Trials
实施循证知情同意实践,以解决临床试验中阿尔茨海默氏症痴呆和认知障碍的风险
  • 批准号:
    9754744
  • 财政年份:
    2018
  • 资助金额:
    $ 47.39万
  • 项目类别:
Implementing Evidence-based Informed Consent Practices to Address the Risk of Alzheimer's Dementia and Cognitive Impairment in Clinical Trials
实施循证知情同意实践,以解决临床试验中阿尔茨海默氏症痴呆和认知障碍的风险
  • 批准号:
    9919368
  • 财政年份:
    2018
  • 资助金额:
    $ 47.39万
  • 项目类别:
Implementing Evidence-based Informed Consent Practices to Address the Risk of Alzheimer's Dementia and Cognitive Impairment in Clinical Trials
实施循证知情同意实践,以解决临床试验中阿尔茨海默氏症痴呆和认知障碍的风险
  • 批准号:
    10394876
  • 财政年份:
    2018
  • 资助金额:
    $ 47.39万
  • 项目类别:
Sharing Qualitative Research Data: Identifying and Addressing Ethical and Practical Barriers
共享定性研究数据:识别和解决道德和实践障碍
  • 批准号:
    9390653
  • 财政年份:
    2017
  • 资助金额:
    $ 47.39万
  • 项目类别:
Preventing ethical disasters in the practice of medicine
预防医学实践中的伦理灾难
  • 批准号:
    8667968
  • 财政年份:
    2013
  • 资助金额:
    $ 47.39万
  • 项目类别:
Preventing ethical disasters in the practice of medicine
预防医学实践中的伦理灾难
  • 批准号:
    9288103
  • 财政年份:
    2013
  • 资助金额:
    $ 47.39万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.39万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 47.39万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了